Issue 3/2016
Content (18 Articles)
Practical Approaches to Diabetes Care: An Introduction
Marc Evans, Abigail Maisey
A Practical Approach to Gastrointestinal Complications of Diabetes
Abigail Maisey
Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
Margaret Bannister, Jenny Berlanga
Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?
Sandro Gentile, Felice Strollo, Antonio Ceriello, S. Gentile, A. Botta, L. Cucco, N. De Rosa, S. De Riu, G. Garrapa, L. Gentile, G. Grassi, C. Lalli, G. Lo Grasso, T. M. Marcone, M. Sudano, P. Tatti, L. Tonutti, R. Chiandetti
Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
Amrita Ostawal, Emina Mocevic, Nana Kragh, Weiwei Xu
Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment
Merlin C. Thomas, Päivi M. Paldánius, Rajeev Ayyagari, Siew Hwa Ong, Per-Henrik Groop
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
Kyle T. Baron, Sreeraj Macha, Uli C. Broedl, Valerie Nock, Silke Retlich, Matthew Riggs
Improving Type 2 Diabetes Patient Health Outcomes with Individualized Continuing Medical Education for Primary Care
Brian Lee, Dace Trence, Silvio Inzucchi, Jay Lin, Steven Haimowitz, Elizabeth Wilkerson, Cara Williams, Marc Mosier, Terry Dex
Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records
Wlodzimierz M. Kolaczynski, Matthew Hankins, Siew H. Ong, Hartmut Richter, Andreas Clemens, Massoud Toussi
How Much Time Do Families Spend on the Health Care of Children with Diabetes?
Jane E. Miller, Colleen N. Nugent, Louise B. Russell
Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers
William Green, Matthew Taylor
Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment
Shira Perl, William Cook, Cheryl Wei, Nayyar Iqbal, Boaz Hirshberg
Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims Study
Ronan Roussel, Bernard Charbonnel, Mourad Behar, Julie Gourmelen, Corinne Emery, Bruno Detournay
Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study
Mohamed Khattab, Khalifa Mahmoud, Inass Shaltout
Clinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study
Vincent Lak, Ann-Marie Svensson, Mervete Miftaraj, Stefan Franzén, Björn Eliasson
Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes
Gregory C. Jones, Zhou M. Chong, Jennifer Gilmour, Christine Matheson, Gordon MacGregor, Christopher A. R. Sainsbury
Postprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus: A Post Hoc Analysis
Bo Ahrén, Gagik Galstyan, Jean-Francois Gautier, Francesco Giorgino, Fernando Gomez-Peralta, Michael Krebs, Elena Nikonova, William Stager, Hernando Vargas-Uricoechea
ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective
Alla K. Ovsyannikova, Oksana D. Rymar, Elena V. Shakhtshneider, Vadim V. Klimontov, Elena A. Koroleva, Natalya E. Myakina, Mikhail I. Voevoda